Context Recent randomized controlled trials (RCTs) examined the role of adding androgen
receptor signaling inhibitors (ARSIs), including abiraterone acetate (ABI), apalutamide, …

Context Prostate-specific membrane antigen positron emission tomography (PSMA-PET) has
gained acceptance as a staging tool for prostate cancer (PCa). Recent reports suggest an …

Management of non-metastatic castration-resistant prostate cancer (nmCRPC) has undergone
a paradigm shift with next-generation androgen receptor inhibitors. However, direct …

Purpose: En bloc resection for bladder tumors has been developed to overcome
shortcomings of conventional transurethral resection of bladder tumors with regard to safety, …

Purpose: Despite the advances in nerve sparing and minimally invasive radical prostatectomy,
erectile dysfunction remains an important adverse event after radical prostatectomy. …

Purpose Androgen-regulated enzymes such as the angiotensin-converting enzyme 2 (ACE2)
and the transmembrane serine protease 2 (TMPRSS2) are involved in the SARS-CoV-2 …

Pembrolizumab is the standard for the first and second lines in treating metastatic urothelial
carcinoma (UC). This systematic review and meta-analysis aimed to assess the value of …

Purpose: Androgen deprivation therapy is a standard therapy for some patients with localized
and almost all patients with metastatic prostate cancer. Although several clinical cohort …

Purpose To assess the differential clinical outcomes of patients treated with partial
nephrectomy (PN) vs. those treated with ablation therapy (AT) such as radiofrequency ablation, …

Objectives To perform a systematic review and network meta‐analysis to compare the efficacy
and safety of currently available treatments for the management of metastatic hormone‐…